Mangrove Partners’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-92,000	Closed	-$1.22M	–	465
2021 Q4	$1.22M	Buy	+92,000	New	+$1.22M	0.07%	409
2021 Q3	–	Hold	0	–	–	–	363
2021 Q2	–	Hold	0	–	–	–	325